Munira Dudhbhai, MD
Obstetrics & Gynecology · Lewisville, TXNPI 1922064724
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.1% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $902 and has fallen 64.1% since, to $324 in 2025.
Across 142 payments — averaging $19.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$621
- Astellas Pharma US Inc$281
- Pfizer$207
- Intuitive Surgical$195
- Mayne Pharma Commercial LLC$143
- Sumitomo Pharma America, Inc.$112
- plus $1K from 26 others
Across 1 payment — averaging $91.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genbiopro, Inc.$91
What the payments were for
- Consulting fees$321%
- Food & beverage$2,51893%
- Education$1556%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $621 |
| Astellas Pharma US Inc | 9 | $281 |
| Pfizer | 9 | $207 |
| Intuitive Surgical | 2 | $195 |
| Mayne Pharma Commercial LLC | 7 | $143 |
| Sumitomo Pharma America, Inc. | 6 | $112 |
| Myovant Sciences Inc. | 6 | $111 |
| Organon | 7 | $109 |
| Aspira Women's Health Inc | 5 | $104 |
| Shield Therapeutics Inc | 3 | $87 |
| Biogen | 5 | $83 |
| Agile Therapeutics, Inc. | 4 | $68 |
| Scynexis, Inc. | 3 | $52 |
| Exact Sciences | 3 | $51 |
| Applied Medical Resources Corporation | 1 | $48 |
| Radius Health, Inc. | 2 | $42 |
| Bayer | 2 | $38 |
| Minerva Surgical, Inc | 1 | $37 |
| Avion Pharmaceuticals | 2 | $34 |
| Mylan Pharmaceuticals Inc. | 2 | $30 |
| Millicent US Inc | 1 | $30 |
| Exeltis, USA Inc. | 2 | $30 |
| Evofem Biosciences, Inc. | 2 | $28 |
| Merck | 2 | $27 |
| Boston Scientific | 2 | $25 |
| Therapeuticsmd, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $18 |
| Duchesnay USA Incorporated | 1 | $17 |
| Coopersurgical, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Dysis Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,704 in reported general payments places this provider in the 70th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Lewisville
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.